SSA
BCAB icon

Schonfeld Strategic Advisors’s BioAtla BCAB Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-664
Closed -$45.5K – 2044
2024
Q2 		$45.5K Buy
+664
New +$79K ﹤0.01% 1943
2022
Q4 		– Sell
-298
Closed -$115K – 2595
2022
Q3 		$115K Sell
298
-626
-68% -$205K ﹤0.01% 2512
2022
Q2 		$132K Sell
924
-542
-37% -$86.3K ﹤0.01% 2061
2022
Q1 		$367K Buy
+1,466
New +$613K ﹤0.01% 1551
2021
Q4 		– Sell
-187
Closed -$276K – 2144
2021
Q3 		$276K Buy
+187
New +$364K ﹤0.01% 1575

Other funds holding BCAB

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Schonfeld Strategic Advisors's BCAB Position: Q3 2024 in Review

Schonfeld Strategic Advisors sold out of BioAtla (BCAB) in Q3 2024, closing a stake of 664 shares — an estimated $45.5K sold.

Schonfeld Strategic Advisors first reported a position in BCAB in Q3 2021 and held it in 5 quarters. The position peaked at $367K in Q1 2022. 63 funds tracked by Wall St. Rank hold BCAB as of Q3 2024.

  • Schonfeld Strategic Advisors reported no remaining BioAtla position as of Q3 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 664 BioAtla shares in Q3 2024, an estimated $45.5K.
  • Schonfeld Strategic Advisors first reported a position in BioAtla in Q3 2021 and held it in 5 quarters.
  • Schonfeld Strategic Advisors's BioAtla position peaked at $367K in Q1 2022.
  • 63 funds tracked by Wall St. Rank held BioAtla as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.